Biomolecular Therapeutics deals with proprietary technology designed to reduce significantly deleterious side effects triggered by conventional siRNA especially, the stimulation of the innate immune system, which makes it feasible to use as iRNA for the treatment of age-related macular degeneration, a disease to which RNAi therapeutics could not be developed using conventional siRNAs. Other potential applications for biomolecular therapeutics technology include therapeutics targeting infectious disease, such as herpes simplex virus (HSV) and cancer.
Related Journals of Biomolecular Therapeutics Companies
Biomolecules — Open Access Journal, Research & Reviews: Journal of Pharmaceutics and Nanotechnology, Nanomaterials & Molecular Nanotechnology, American Journal of Industrial Medicine, Journal of Biomedical Nanotechnology, Nigerian Journal of Chemical Research, International Journal of Scientific Research, Chemistry Education Research and Practice, Macromolecular Theory and Simulations, Proteomics, Chemistry: An Indian Journal.